Contact form:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Results of double-blind, randomized controlled trial published in The Lancet

January 1, 2021

Unity HA announces the publication of the results of a randomized, sham-controlled, parallel group, double-blind, safety and efficacy study at 21 headache centers in the USA.   This publication in The Lancet Neurology Journal further demonstrates that sphenopalatine ganglion stimulation is efficacious and well tolerated therapy which offers an alternative approach to the treatment of chronic cluster headache.

Chronic cluster headache is the most disabling form of cluster headache. The mainstay of treatment is attack prevention, but the available management options have little efficacy and are associated with substantial side-effects. In this study, we aimed to assess the safety and efficacy of sphenopalatine ganglion stimulation for treatment of chronic cluster headache.